Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
06/2008
06/05/2008WO2008064451A1 Poxviridae treatment comprising tap-1 and/or tap-2 as a molecular adjuvant
06/05/2008WO2008064425A1 Glycoalkaloid and chemotherapeutic agent combinations and various uses thereof
06/05/2008WO2008043791A3 Thiophene derivatives for treating hepatitis c
06/05/2008WO2008042240A3 Enantiomerically pure phosphoindoles as hiv inhibitors
06/05/2008WO2008017473A3 Structure and use of 5' phosphate oligonucleotides
06/05/2008WO2007113224A3 Conjugation process for pnag and a carrier protein
06/05/2008US20080132706 Compounds as PDE IV and TNF Inhibitors
06/05/2008US20080132704 3-Substituted quinuclidines and their use
06/05/2008US20080132678 Such as N-(4-morpholine)carbonyl-(O-benzyl)-L-tyrosine-L-leucine boronic acid for reducing rate of degradation of proteins; proteasome inhibitors
06/05/2008US20080132574 Leukotriene B4 receptor binding activity; treatment of skin disease such as psoriasis, eczema, skin cancer, keratosis, dyspigmentation or psilosis
06/05/2008US20080132565 Polycyclic Macrolactones
06/05/2008US20080132549 Sulphur-Linked Imidazone Compounds for the Treatment of Hiv/Aids
06/05/2008US20080132547 (R)-2-(((3-methyl-4-(2,2,2-trifluoroethoxy)-2 -pyridinyl)methyl)sulfinyl)-1H-benzimidazole, (R(+)-lansoprazole); antiulcer agent
06/05/2008US20080132537 Viricides; antiinflammatory agents; infection therapy; respiratory system disorders
06/05/2008US20080132533 Solid Dispersion Comprising Tacrolimus and Entericcoated Macromolecule
06/05/2008US20080132530 polymorphic forms alpha , beta and gamma; for the oral or topical route; In case of invasive bacteria, it may be useful to use the most bioavailable polymorphic form, whereas in case of non-invasive pathogens it may be more appropriate to use the less adsorbed forms, since they are safer
06/05/2008US20080132527 Compositions For Delivering Acyclovir
06/05/2008US20080132516 Viricides, immunomodulators or HIV entry inhibitors; lymphadenopathy associated virus, human T-cell leukemia/lymphoma virus; AIDS
06/05/2008US20080132500 Antibiotic compounds
06/05/2008US20080132481 Use of 3-substituted amino-2-carboxy-substituted indoles or benzo(b)thiophenes or esters thereof that modulate T helper (Th) cells; treating allergy, asthma, rhinitis, dermatitis, B-cell lymphomas, tumors and diseases associated with bacterial, rhinovirus or respiratory syncytial virus (RSV) infections
06/05/2008US20080132478 Modified release amoxicillin products
06/05/2008US20080132459 Inhibitors of Histone Deacetylase
06/05/2008US20080132457 Bacterial efflux pump inhibitors for the treatment of ophthalmic and otic infections
06/05/2008US20080132448 Conserved neisserial antigens
06/05/2008US20080132442 biodegradable drug delivery system; fungal infection; inflammation; injection
06/05/2008US20080131871 Using vector comprisng nucleotide sequences coding cell binding elements to transform cells and identify lymphocyte response modulators
06/05/2008US20080131565 Edible composition; partially defatted cocoa solids prepared by heating slaty and/or purple cocoa beans, winnowing the cocoa nibs from the cocoa shells; pressing the cocoa nibs to produce cocoa butter, recovering the cocoa butter and solids; adding the recovered, defatted cocoa solids
06/05/2008US20080131535 Skin protection composition
06/05/2008US20080131529 Herba houftuyniae, caulis lonicerae japonicae, radix isatidis, radix et rhizoma sophorae tonkinensis, and other herbs made into a cream by boiling and solvent extraction steps; safer, inexpensive
06/05/2008US20080131524 Compositions for treatment of viral-induced skin lesions and methods of using same
06/05/2008US20080131519 Omega-3-polyunsaturated fatty acid ester, in fish oil concentrate containing a 5,8,11,14,17-eicosapentaenic acid ester and a 4,7,10,13,16,19-docosahexaenic acid ester, also lysine of a salt, optionally a zinc salt, or selenium
06/05/2008US20080131516 Granule formation
06/05/2008US20080131499 Method and composition for solubilising a biologically active compound with low water solubilty
06/05/2008US20080131462 Genus acidophilus, crispatus, gasseri, helveticus and/or jensenii; killing and inhibiting internalization of urogenital and/or gastrointestinal pathogens
06/05/2008US20080131460 Administration of monovalent vaccine comprising first serotype vaccinal virus followed 1 to 12 months later by tetravalent vaccine; kits
06/05/2008US20080131454 Methods and Compositions for the Treatment of Rhinovirus Infections with Carrageenan
06/05/2008US20080131447 Using alkyl hydroperoxide reductase as tool in developing vaccines to prevent and treat microorganismal infection; immunotherapy
06/05/2008US20080131438 Antibodies to non-functional p2x7 receptor
06/05/2008US20080131423 Triggering receptors expressed on myeloid cells (TREMs) specific immunoglobulin for use in prevention and treatment of blood coagulation disorders
06/05/2008US20080131399 Using interferon alpha chimera to treat and prevent cell proliferative and viral diseases
06/05/2008US20080131398 Combination therapy for treatment of viral infections
06/05/2008US20080128315 Resorbable Pouches for Implantable Medical Devices
06/05/2008CA2673757A1 Poxviridae treatment
06/05/2008CA2670965A1 Influenza vaccine formulation
06/05/2008CA2670953A1 An oral hygiene composition comprising myrtle
06/05/2008CA2670939A1 Oral health composition
06/05/2008CA2670595A1 (r)-5-methyl-4,5-dihydro-pyrazole-1,5-dicarboxylic acid 1-[(4-chlorophenyl)amide 5-{[2-fluoro-4-(2-oxo-2h-pyridin-1-yl)-phenyl)amide) as a fact or xa inhibitor
06/05/2008CA2670440A1 Use of beta-lactamase
06/05/2008CA2668570A1 Immunization protocol against the 4 dengue serotypes
06/04/2008WO2008068923A1 Nucleic acid-degrading agent and method for degradation of nucleic acid
06/04/2008EP1927589A1 Quinoline derivatives
06/04/2008EP1927368A2 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
06/04/2008EP1927366A1 Combination vaccine against streptococcus pneumoniae and respiratory syncytial virus (RSV)
06/04/2008EP1926733A2 Tetracyclic indole derivatives as antiviral agents
06/04/2008EP1926496A1 Pcv-2 vaccine
06/04/2008EP1926495A2 Therapeutic use of outer shigella protein f (os pf)
06/04/2008EP1487817B1 Piperidine derivatives useful as modulators of chemokine receptor activity
06/04/2008EP1463754B1 Cystine-knot fold protein
06/04/2008EP1377316B1 Pharmaceutical composition based on azalides for topical application in ophthalmology
06/04/2008EP1365781B1 Acrochordon alleviation
06/04/2008EP1345954B1 Methods utilizing aryl thioimines in synthesis of erythromycin derivatives
06/04/2008EP1322327B1 Stabilisation of plasmid inheritance in bacteria by preventing multimerisation
06/04/2008EP1237887B1 9-(piperazinylalkyl)carbazoles as bax-modulators
06/04/2008EP1233971B1 6-o-alkyl-2-nor-2-substituted ketolide derivatives
06/04/2008EP1195162B1 Vaccine preparation containing fatty acid as a constituent
06/04/2008EP1028749B1 Enterococcus antigens and vaccines
06/04/2008EP0931071B1 Methods of making hiv-protease inhibitors and intermediates for making them
06/04/2008EP0672143B1 Lymphotoxin-beta, lymphotoxin-beta complexes, pharmaceutical preparations and therapeutic uses thereof
06/04/2008CN101194012A Process of manufacturing viral vaccines in suspension avian embryonic derived stem cell lines
06/04/2008CN101193892A Macrocyclic heterocyclic aspartyl protease inhibitors
06/04/2008CN101193891A 2-thioethenyl substituted carbapenem derivatives
06/04/2008CN101193882A N-formyl hydroxylamine compounds as PDF inhibitor
06/04/2008CN101193859A The preparation and use of compounds as protease inhibitors
06/04/2008CN101193682A Pharmaceutical composition comprising an antiviral agent, an antitumoral agent or an antiparasitic agent, and an active agent selected among carveol, thymol, eugenol, borneol and carvacrol
06/04/2008CN101191130A ChIFNGR1 gene and its coding protein and application
06/04/2008CN101191129A Gene engineering domestic silkworm antibiotic peptide and its preparation method and application
06/04/2008CN101190944A Human cytokine and use thereof
06/04/2008CN101190938A Compound used for liver disease
06/04/2008CN101190937A Compound with liver-protecting activity
06/04/2008CN101190936A Compound with antiviral activity
06/04/2008CN101190935A Compound used for viral infect
06/04/2008CN101190933A 6-O-methylerythromycin A crystal form III
06/04/2008CN101190922A Cephalosporin derivative
06/04/2008CN101190913A Novel compound with antiviral activity
06/04/2008CN101190904A Fatty acid synthetic enzyme inhibitor and medical preparation use thereof
06/04/2008CN101190894A Fatty acid synthetic enzyme inhibitor and medical preparation use thereof
06/04/2008CN101190883A Novel compound with antiviral activity
06/04/2008CN101190332A Vibrio anguilarum oil oral-emulsified bivalent vaccine and preparation thereof
06/04/2008CN101190328A Day coriander traditional Chinese medicine spray agent
06/04/2008CN101190324A Externally-used tincture for treating hepatitis B
06/04/2008CN101190323A Orally-taken traditional Chinese medicine soup acquired immuno-deficiency syndrome
06/04/2008CN101190322A Traditional Chinese medicine for treating zoster post herpetic neuralgia
06/04/2008CN101190303A Traditional Chinese medicine preparation for treating exogenous affected hyperthermia symptoms
06/04/2008CN101190282A Sugar-free compound traditional Chinese medicinal preparation for treating upper respiratory tract infection and quality control method thereof
06/04/2008CN101190274A Traditional Chinese medicinal composition for treating rabies
06/04/2008CN101190263A Rhubarb chewable tablets and preparation method and application thereof
06/04/2008CN101190260A Jinling common cold preparation and controlled releasing preparations and preparation method thereof
06/04/2008CN101190257A Externally-used medicine bag for traditional Chinese medicinal composition for preventing and controlling infantile common cold
06/04/2008CN101190237A Anti-cold drugs containing dexibuprofen
06/04/2008CN101190233A Erythromycin chewable tablets for dog or cat
1 ... 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 ... 1798